acetylcysteine has been researched along with o-(chloroacetylcarbamoyl)fumagillol in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Bigda, J; Kamysz, W; Mysliwski, A; Okrój, M; Slominska, EM | 1 |
2 other study(ies) available for acetylcysteine and o-(chloroacetylcarbamoyl)fumagillol
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
A novel mechanism of action of the fumagillin analog, TNP-470, in the B16F10 murine melanoma cell line.
Topics: Acetylcysteine; Animals; Antibiotics, Antineoplastic; Cells, Cultured; Cyclohexanes; Endothelial Cells; HeLa Cells; Humans; In Vitro Techniques; Kidney; Melanoma, Experimental; Mice; O-(Chloroacetylcarbamoyl)fumagillol; Reactive Oxygen Species; Sesquiterpenes | 2005 |